MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine

[1]  G. Milligan,et al.  MicroRNA regulation of endothelial homeostasis and commitment-implications for vascular regeneration strategies using stem cell therapies. , 2013, Free radical biology & medicine.

[2]  E. Porrello.  microRNAs in cardiac development and regeneration. , 2013, Clinical science.

[3]  C. Emanueli,et al.  Local Inhibition of MicroRNA-24 Improves Reparative Angiogenesis and Left Ventricle Remodeling and Function in Mice With Myocardial Infarction , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[4]  Onju Ham,et al.  MicroRNA-145 suppresses ROS-induced Ca2+ overload of cardiomyocytes by targeting CaMKIIδ. , 2013, Biochemical and biophysical research communications.

[5]  G. Wang,et al.  mir-17–92 Cluster Is Required for and Sufficient to Induce Cardiomyocyte Proliferation in Postnatal and Adult Hearts , 2013, Circulation research.

[6]  Kavitha T. Kuppusamy,et al.  MicroRNA regulation and role in stem cell maintenance, cardiac differentiation and hypertrophy. , 2013, Current molecular medicine.

[7]  P. Doevendans,et al.  Targeting cell death in the reperfused heart: pharmacological approaches for cardioprotection. , 2013, International journal of cardiology.

[8]  D. Srivastava,et al.  Small solutions to big problems: microRNAs for cardiac regeneration. , 2013, Circulation research.

[9]  Andreia J. Amaral,et al.  Expression Profile of microRNAs Regulating Proliferation and Differentiation in Mouse Adult Cardiac Stem Cells , 2013, PloS one.

[10]  Ming Xu,et al.  miRNA-711-SP1-collagen-I pathway is involved in the anti-fibrotic effect of pioglitazone in myocardial infarction , 2013, Science China Life Sciences.

[11]  M. Goumans,et al.  microRNA-1 enhances the angiogenic differentiation of human cardiomyocyte progenitor cells , 2013, Journal of Molecular Medicine.

[12]  I. Karakikes,et al.  Therapeutic Cardiac‐Targeted Delivery of miR‐1 Reverses Pressure Overload–Induced Cardiac Hypertrophy and Attenuates Pathological Remodeling , 2013, Journal of the American Heart Association.

[13]  H. Hermeking,et al.  MicroRNA-34a regulates cardiac ageing and function , 2013, Nature.

[14]  R. Kalluri,et al.  miR-21 Promotes Fibrogenic Epithelial-to-Mesenchymal Transition of Epicardial Mesothelial Cells Involving Programmed Cell Death 4 and Sprouty-1 , 2013, PloS one.

[15]  Sheng-hua Zhou,et al.  Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival. , 2013, International journal of molecular medicine.

[16]  F. Solé,et al.  Identification of Temporal and Region-Specific Myocardial Gene Expression Patterns in Response to Infarction in Swine , 2013, PloS one.

[17]  M. Rudin,et al.  Loss of AngiomiR-126 and 130a in Angiogenic Early Outgrowth Cells From Patients With Chronic Heart Failure: Role for Impaired In Vivo Neovascularization and Cardiac Repair Capacity , 2012, Circulation.

[18]  Diana C. Canseco,et al.  Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family , 2012, Proceedings of the National Academy of Sciences.

[19]  Yan Wang,et al.  Circulating miR-30a, miR-195 and let-7b Associated with Acute Myocardial Infarction , 2012, PloS one.

[20]  L. Zentilin,et al.  Functional screening identifies miRNAs inducing cardiac regeneration , 2012, Nature.

[21]  Y. Liu,et al.  MicroRNA-204 is required for differentiation of human-derived cardiomyocyte progenitor cells. , 2012, Journal of molecular and cellular cardiology.

[22]  Yanjie Lu,et al.  A novel reciprocal loop between microRNA-21 and TGFβRIII is involved in cardiac fibrosis. , 2012, The international journal of biochemistry & cell biology.

[23]  Richard T. Lee,et al.  Mammalian Heart Renewal by Preexisting Cardiomyocytes , 2012, Nature.

[24]  Savita Khanna,et al.  The MicroRNA miR-199a-5p Down-regulation Switches on Wound Angiogenesis by Derepressing the v-ets Erythroblastosis Virus E26 Oncogene Homolog 1-Matrix Metalloproteinase-1 Pathway* , 2012, The Journal of Biological Chemistry.

[25]  S. Kauppinen,et al.  Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function , 2012, Proceedings of the National Academy of Sciences.

[26]  P. Doevendans,et al.  Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs , 2012, EMBO molecular medicine.

[27]  M. Yamakuchi.  MicroRNAs in Vascular Biology , 2012, International journal of vascular medicine.

[28]  Ruotian Li,et al.  MicroRNA-145 Protects Cardiomyocytes against Hydrogen Peroxide (H2O2)-Induced Apoptosis through Targeting the Mitochondria Apoptotic Pathway , 2012, PloS one.

[29]  Shengshou Hu,et al.  MicroRNA-24 regulates cardiac fibrosis after myocardial infarction , 2012, Journal of cellular and molecular medicine.

[30]  Yanjie Lu,et al.  MicroRNA-101 Inhibited Postinfarct Cardiac Fibrosis and Improved Left Ventricular Compliance via the FBJ Osteosarcoma Oncogene/Transforming Growth Factor-&bgr;1 Pathway , 2012, Circulation.

[31]  Ha Won Kim,et al.  Stem cell-based delivery of Hypoxamir-210 to the infarcted heart: implications on stem cell survival and preservation of infarcted heart function , 2012, Journal of Molecular Medicine.

[32]  D. Bernstein,et al.  Dynamic microRNA expression during the transition from right ventricular hypertrophy to failure. , 2012, Physiological genomics.

[33]  K. Poss,et al.  Regulation of zebrafish heart regeneration by miR-133. , 2012, Developmental biology.

[34]  E. Olson,et al.  MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca²⁺ overload and cell death. , 2012, The Journal of clinical investigation.

[35]  C. Sen,et al.  miR‐210: The Master Hypoxamir , 2012, Microcirculation.

[36]  Li Lin,et al.  Overexpression of microRNA-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes , 2012, Apoptosis.

[37]  S. Dimmeler,et al.  MicroRNAs and Stem Cells: Control of Pluripotency, Reprogramming, and Lineage Commitment , 2012, Circulation research.

[38]  T. Boettger,et al.  A New Level of Complexity: The Role of MicroRNAs in Cardiovascular Development , 2012, Circulation research.

[39]  J. Mendell,et al.  MicroRNAs in Stress Signaling and Human Disease , 2012, Cell.

[40]  I. Knezevic,et al.  A Novel Cardiomyocyte-enriched MicroRNA, miR-378, Targets Insulin-like Growth Factor 1 Receptor , 2012, The Journal of Biological Chemistry.

[41]  R. Hajjar,et al.  SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway , 2012, European heart journal.

[42]  M. Abdellatif.  Differential Expression of MicroRNAs in Different Disease States , 2012, Circulation research.

[43]  E. van Rooij,et al.  Developing microRNA therapeutics. , 2012, Circulation research.

[44]  E. Olson,et al.  Inhibition of miR-15 Protects Against Cardiac Ischemic Injury , 2012, Circulation research.

[45]  N. Frangogiannis,et al.  Regulation of the inflammatory response in cardiac repair. , 2012, Circulation research.

[46]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association. , 2012, Circulation.

[47]  Luigi Atzori,et al.  MiR-1 Downregulation Cooperates with MACC1 in Promoting MET Overexpression in Human Colon Cancer , 2011, Clinical Cancer Research.

[48]  M. Goumans,et al.  MicroRNA-214 inhibits angiogenesis by targeting Quaking and reducing angiogenic growth factor release. , 2012, Cardiovascular research.

[49]  T. Eckle,et al.  Ischemia and reperfusion—from mechanism to translation , 2011, Nature Medicine.

[50]  S. Kreth,et al.  MicroRNAs as potential therapeutic agents in the treatment of myocardial infarction. , 2011, Current vascular pharmacology.

[51]  R. Mutharasan,et al.  microRNA-210 is upregulated in hypoxic cardiomyocytes through Akt- and p53-dependent pathways and exerts cytoprotective effects. , 2011, American journal of physiology. Heart and circulatory physiology.

[52]  F. Salloum,et al.  MicroRNAs: New Players in Cardiac Injury and Protection , 2011, Molecular Pharmacology.

[53]  N. Kosaka,et al.  Unraveling the Mystery of Cancer by Secretory microRNA: Horizontal microRNA Transfer between Living Cells , 2011, Front. Gene..

[54]  P. Nguyen,et al.  Novel MicroRNA Prosurvival Cocktail for Improving Engraftment and Function of Cardiac Progenitor Cell Transplantation , 2011, Circulation.

[55]  M. Odenthal,et al.  Hepatocyte Growth Factor (HGF) Inhibits Collagen I and IV Synthesis in Hepatic Stellate Cells by miRNA-29 Induction , 2011, PloS one.

[56]  G. Dorn,et al.  miR-15 Family Regulates Postnatal Mitotic Arrest of Cardiomyocytes , 2011, Circulation research.

[57]  T. Tuschl,et al.  MicroRNA-24 Regulates Vascularity After Myocardial Infarction , 2011, Circulation.

[58]  J. Qian,et al.  miR-29 is a major regulator of genes associated with pulmonary fibrosis. , 2011, American journal of respiratory cell and molecular biology.

[59]  Toshihiro Tamura,et al.  Increased MicroRNA-1 and MicroRNA-133a Levels in Serum of Patients With Cardiovascular Disease Indicate Myocardial Damage , 2011, Circulation. Cardiovascular genetics.

[60]  Barry Greenberg,et al.  Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): A Phase 2 Trial of Intracoronary Gene Therapy of Sarcoplasmic Reticulum Ca2+-ATPase in Patients With Advanced Heart Failure , 2011, Circulation.

[61]  X. Ni,et al.  MiR-204 regulates cardiomyocyte autophagy induced by ischemia-reperfusion through LC3-II , 2011, Journal of Biomedical Science.

[62]  X. Gidrol,et al.  Pre-microRNA and Mature microRNA in Human Mitochondria , 2011, PloS one.

[63]  Koh Ono,et al.  MicroRNAs and cardiovascular diseases , 2011, The FEBS journal.

[64]  M. Abdellatif,et al.  MicroRNAs in the cardiovascular system , 2011, Current opinion in cardiology.

[65]  Marcello Rota,et al.  Human Cardiac Stem Cell Differentiation Is Regulated by a Mircrine Mechanism , 2011, Circulation.

[66]  L. V. Van Laake,et al.  miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes , 2011, The Journal of experimental medicine.

[67]  T. Crepaldi,et al.  Novel therapy for myocardial infarction: can HGF/Met be beneficial? , 2011, Cellular and Molecular Life Sciences.

[68]  A. Chiribiri,et al.  Activated Met Signalling in the Developing Mouse Heart Leads to Cardiac Disease , 2011, PloS one.

[69]  Jan A Staessen,et al.  Circulating MicroRNA-208b and MicroRNA-499 Reflect Myocardial Damage in Cardiovascular Disease , 2010, Circulation. Cardiovascular genetics.

[70]  S. Kauppinen,et al.  Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. , 2010, The Journal of clinical investigation.

[71]  M. Medvedovic,et al.  MicroRNA-494 Targeting Both Proapoptotic and Antiapoptotic Proteins Protects Against Ischemia/Reperfusion-Induced Cardiac Injury , 2010, Circulation.

[72]  Fabio Martelli,et al.  MicroRNA-210 as a Novel Therapy for Treatment of Ischemic Heart Disease , 2010, Circulation.

[73]  Chunxiang Zhang,et al.  Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. , 2010, Cardiovascular research.

[74]  E. van Rooij,et al.  MicroRNA regulation as a therapeutic strategy for cardiovascular disease. , 2010, Current drug targets.

[75]  Sadakatsu Ikeda,et al.  Expression and function of microRNAs in heart disease. , 2010, Current drug targets.

[76]  P. Huang,et al.  Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression , 2010, Oncogene.

[77]  S. Anker,et al.  MicroRNAs as circulating biomarkers for heart failure: questions about MiR-423-5p. , 2010, Circulation research.

[78]  Borivoj Vojnovic,et al.  MicroRNA-210 Regulates Mitochondrial Free Radical Response to Hypoxia and Krebs Cycle in Cancer Cells by Targeting Iron Sulfur Cluster Protein ISCU , 2010, PloS one.

[79]  E. Olson,et al.  MicroRNA regulatory networks in cardiovascular development. , 2010, Developmental cell.

[80]  Perry D Moerland,et al.  MiR423-5p As a Circulating Biomarker for Heart Failure , 2010, Circulation research.

[81]  E. Rooij,et al.  miRNAs as Therapeutic Targets in Ischemic Heart Disease , 2010, Journal of cardiovascular translational research.

[82]  Ryan M. Anderson,et al.  Primary contribution to zebrafish heart regeneration by gata4+ cardiomyocytes , 2010, Nature.

[83]  E. Olson,et al.  MicroRNAs add a new dimension to cardiovascular disease. , 2010, Circulation.

[84]  Yue Li,et al.  Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. , 2010, European heart journal.

[85]  Zhaoyong Hu,et al.  Downregulation of microRNA-29 by antisense inhibitors and a PPAR-gamma agonist protects against myocardial ischaemia-reperfusion injury. , 2010, Cardiovascular research.

[86]  J. C. Belmonte,et al.  Zebrafish heart regeneration occurs by cardiomyocyte dedifferentiation and proliferation , 2010, Nature.

[87]  Z. Pan,et al.  The roles of microRNAs in heart diseases: a novel important regulator. , 2010, Current medicinal chemistry.

[88]  Jincheng Li,et al.  miR-30 Regulates Mitochondrial Fission through Targeting p53 and the Dynamin-Related Protein-1 Pathway , 2010, PLoS genetics.

[89]  D. Catalucci,et al.  Reciprocal Regulation of MicroRNA-1 and Insulin-Like Growth Factor-1 Signal Transduction Cascade in Cardiac and Skeletal Muscle in Physiological and Pathological Conditions , 2009, Circulation.

[90]  E. Olson,et al.  A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. , 2009, Developmental cell.

[91]  Joseph Loscalzo,et al.  MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. , 2009, Cell metabolism.

[92]  Shujia Jiang,et al.  Ischemic Preconditioning Augments Survival of Stem Cells via miR-210 Expression by Targeting Caspase-8-associated Protein 2* , 2009, The Journal of Biological Chemistry.

[93]  Chunxiang Zhang,et al.  MicroRNA Expression Signature and the Role of MicroRNA-21 in the Early Phase of Acute Myocardial Infarction* , 2009, The Journal of Biological Chemistry.

[94]  Chunxiang Zhang,et al.  MicroRNA-21 protects against the H(2)O(2)-induced injury on cardiac myocytes via its target gene PDCD4. , 2009, Journal of molecular and cellular cardiology.

[95]  Stefanie Dimmeler,et al.  MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice , 2009, Science.

[96]  Maureen A. Sartor,et al.  MicroRNA-320 Is Involved in the Regulation of Cardiac Ischemia/Reperfusion Injury by Targeting Heat-Shock Protein 20 , 2009, Circulation.

[97]  Yan Sun,et al.  MicroRNA-1 regulates cardiomyocyte apoptosis by targeting Bcl-2. , 2009, International heart journal.

[98]  You-yi Zhang,et al.  Upregulated expression of miR-1/miR-206 in a rat model of myocardial infarction. , 2009, Biochemical and biophysical research communications.

[99]  S. Vatner,et al.  Downregulation of MiR-199a Derepresses Hypoxia-Inducible Factor-1α and Sirtuin 1 and Recapitulates Hypoxia Preconditioning in Cardiac Myocytes , 2009, Circulation research.

[100]  G. Nuovo,et al.  MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue. , 2009, Cardiovascular research.

[101]  Derek J Van Booven,et al.  Reciprocal Regulation of Myocardial microRNAs and Messenger RNA in Human Cardiomyopathy and Reversal of the microRNA Signature by Biomechanical Support , 2009, Circulation.

[102]  T. Golub,et al.  MicroRNA-1 Negatively Regulates Expression of the Hypertrophy-Associated Calmodulin and Mef2a Genes , 2009, Molecular and Cellular Biology.

[103]  R. Duisters,et al.  MIRNA-133 AND MIRNA-30 REGULATE CONNECTIVE TISSUE GROWTH FACTOR: IMPLICATIONS FOR A ROLE OF MIRNAS IN MYOCARDIAL MATRIX REMODELING , 2013 .

[104]  W. Rottbauer,et al.  MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts , 2008, Nature.

[105]  E. Olson,et al.  microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. , 2008, Genes & development.

[106]  H. Sweeney,et al.  Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat. , 2008, Human gene therapy.

[107]  Vijay G Divakaran,et al.  The Emerging Role of MicroRNAs in Cardiac Remodeling and Heart Failure , 2008, Circulation research.

[108]  L. Zentilin,et al.  Notch1 signaling stimulates proliferation of immature cardiomyocytes , 2008, The Journal of cell biology.

[109]  Jeffrey E. Thatcher,et al.  Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis , 2008, Proceedings of the National Academy of Sciences.

[110]  John McAnally,et al.  The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. , 2008, Developmental cell.

[111]  Danish Sayed,et al.  MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. , 2008, Molecular biology of the cell.

[112]  J. Port,et al.  miRNA expression in the failing human heart: functional correlates. , 2008, Journal of molecular and cellular cardiology.

[113]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[114]  M. V. van Amerongen,et al.  Features of cardiomyocyte proliferation and its potential for cardiac regeneration , 2008, Journal of cellular and molecular medicine.

[115]  Fabio Martelli,et al.  MicroRNA-210 Modulates Endothelial Cell Response to Hypoxia and Inhibits the Receptor Tyrosine Kinase Ligand Ephrin-A3* , 2008, Journal of Biological Chemistry.

[116]  P. Vliet,et al.  Progenitor cells isolated from the human heart: a potential cell source for regenerative therapy , 2008, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

[117]  E. Olson,et al.  MicroRNAs flex their muscles. , 2008, Trends in genetics : TIG.

[118]  Richard T. Lee,et al.  Stem-cell therapy for cardiac disease , 2008, Nature.

[119]  W. Filipowicz,et al.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.

[120]  H. Hermeking.  p53 enters the microRNA world. , 2007, Cancer cell.

[121]  Chaoqian Xu,et al.  The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes , 2007, Journal of Cell Science.

[122]  Jian-Fu Chen,et al.  Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. , 2007, Journal of molecular and cellular cardiology.

[123]  C. Croce,et al.  MicroRNA-133 controls cardiac hypertrophy , 2007, Nature Medicine.

[124]  Xiaoxia Qi,et al.  Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA , 2007, Science.

[125]  Michael T. McManus,et al.  Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2 , 2007, Cell.

[126]  A. Gabrielsen,et al.  Gene expression signals involved in ischemic injury, extracellular matrix composition and fibrosis defined by global mRNA profiling of the human left ventricular myocardium. , 2007, Journal of molecular and cellular cardiology.

[127]  K. Bicknell,et al.  Can the cardiomyocyte cell cycle be reprogrammed? , 2007, Journal of molecular and cellular cardiology.

[128]  W. R. MacLellan,et al.  Cardiac myocyte cell cycle control in development, disease, and regeneration. , 2007, Physiological reviews.

[129]  Thomas Thum,et al.  MicroRNAs in the Human Heart: A Clue to Fetal Gene Reprogramming in Heart Failure , 2007, Circulation.

[130]  H. de Groot,et al.  Ischemia-reperfusion injury: processes in pathogenetic networks: a review. , 2007, Transplantation proceedings.

[131]  Danish Sayed,et al.  MicroRNAs Play an Essential Role in the Development of Cardiac Hypertrophy , 2007, Circulation research.

[132]  E. Wentzel,et al.  A Hexanucleotide Element Directs MicroRNA Nuclear Import , 2007, Science.

[133]  Wenbin Ye,et al.  MiRNA-Directed Regulation of VEGF and Other Angiogenic Factors under Hypoxia , 2006, PloS one.

[134]  G. Lanfranchi,et al.  Differential gene expression profiling in genetic and multifactorial cardiovascular diseases. , 2006, Journal of molecular and cellular cardiology.

[135]  E. Olson,et al.  A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure , 2006, Proceedings of the National Academy of Sciences.

[136]  Jian-Fu Chen,et al.  The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation , 2006, Nature Genetics.

[137]  Stijn van Dongen,et al.  miRBase: microRNA sequences, targets and gene nomenclature , 2005, Nucleic Acids Res..

[138]  Wei Pan,et al.  A comparative study of discriminating human heart failure etiology using gene expression profiles , 2005, BMC Bioinformatics.

[139]  Yong Zhao,et al.  Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis , 2005, Nature.

[140]  Gregory J. Hannon,et al.  MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies , 2005, Nature Cell Biology.

[141]  R. Irizarry,et al.  Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure. , 2005, Physiological genomics.

[142]  Despina Sanoudou,et al.  Array lessons from the heart: focus on the genome and transcriptome of cardiomyopathies. , 2005, Physiological genomics.

[143]  K. Margulies,et al.  Mixed Messages: Transcription Patterns in Failing and Recovering Human Myocardium , 2005, Circulation research.

[144]  J. Castle,et al.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs , 2005, Nature.

[145]  Haiwei Song,et al.  The enzymes and control of eukaryotic mRNA turnover , 2004, Nature Structural &Molecular Biology.

[146]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[147]  G. Fishman,et al.  Regulation of peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) and mitochondrial function by MEF2 and HDAC5 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[148]  Stephen L. Johnson,et al.  Mps1 defines a proximal blastemal proliferative compartment essential for zebrafish fin regeneration. , 2002, Development.

[149]  P. Anversa,et al.  Myocyte renewal and ventricular remodelling , 2002, Nature.

[150]  M. Franklin,et al.  Cardiomyocyte DNA synthesis and binucleation during murine development. , 1996, The American journal of physiology.

[151]  A. Gerdes,et al.  Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. , 1996, Journal of molecular and cellular cardiology.

[152]  Z. Darżynkiewicz,et al.  Myocyte cellular hyperplasia and myocyte cellular hypertrophy contribute to chronic ventricular remodeling in coronary artery narrowing-induced cardiomyopathy in rats. , 1994, Circulation research.

[153]  P. Anversa,et al.  Impairment of myocyte contractility following coronary artery narrowing is associated with activation of the myocyte IGF1 autocrine system, enhanced expression of late growth related genes, DNA synthesis, and myocyte nuclear mitotic division in rats. , 1993, Experimental cell research.

[154]  Michal Linial,et al.  Working together: combinatorial regulation by microRNAs. , 2013, Advances in experimental medicine and biology.

[155]  W. Yuan,et al.  Induction of microRNA-24 by HIF-1 protects against ischemic injury in rat cardiomyocytes. , 2012, Physiological research.

[156]  Ronald A. Li,et al.  MicroRNA profiling predicts a variance in the proliferative potential of cardiac progenitor cells derived from neonatal and adult murine hearts. , 2012, Journal of molecular and cellular cardiology.

[157]  Sheng-hua Zhou,et al.  Mesenchymal stem cells overexpressing MiR-126 enhance ischemic angiogenesis via the AKT/ERK-related pathway. , 2011, Cardiology journal.

[158]  Yanrui Li,et al.  miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1 , 2011, Nature Medicine.

[159]  Kang Li,et al.  Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. , 2010, Biochemical and biophysical research communications.

[160]  L. Buja,et al.  Unresolved issues in myocardial reperfusion injury. , 2010, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[161]  M. Ivan,et al.  microRNA: emerging therapeutic targets in acute ischemic diseases. , 2010, Pharmacology & therapeutics.

[162]  K. Esser,et al.  MicroRNA-1 and microRNA-133a expression are decreased during skeletal muscle hypertrophy. , 2007, Journal of applied physiology.

[163]  G. Fishman,et al.  Regulation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha ) and mitochondrial function by MEF2 and HDAC5. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[164]  A. Katz,et al.  Evidence that human cardiac myocytes divide after myocardial infarction. , 2001, The New England journal of medicine.